Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$11,836,642
+$1,717,050 QoQ
Shares Held
47,038
+1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.49%
of 13F equity value
Holder Rank
#839
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BENEDICT FINANCIAL ADVISORS INC holds $49,408,945 across 8 Drug Manufacturers - General names. ABBV ranks #3 (24.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,991 | $15,489,884 | |
| 2 | AMGN |
Amgen Inc
|
33,255 | $12,042,300 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
47,038 | $11,836,642 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
70,088 | $4,038,470 | |
| 5 | NVS |
Novartis AG
|
17,055 | $2,672,859 | |
| 6 | NVO |
Novo Nordisk A S
|
33,754 | $1,618,166 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,812 | $1,492,328 | |
| 8 | LLY |
ELI LILLY & Co
|
182 | $218,296 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,836,642 | 47,038 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $10,119,592 | 46,529 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $10,737,659 | 46,994 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $10,881,916 | 46,998 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $8,638,754 | 46,540 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,641,691 | 46,018 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $8,147,545 | 45,850 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $9,003,903 | 45,594 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,878,085 | 45,931 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $8,289,738 | 45,523 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $6,943,895 | 44,808 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $6,512,282 | 43,689 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $5,666,743 | 42,060 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,538,951 | 41,030 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,228,934 | 38,543 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,005,227 | 37,294 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $5,413,287 | 35,344 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $5,473,806 | 33,766 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $4,037,357 | 29,818 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,355,125 | 21,833 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,949,460 | 17,307 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,013,913 | 9,369 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $799,124 | 7,458 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $603,319 | 6,888 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $282,660 | 2,879 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $215,236 | 2,825 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||